Definition of Lexatumumab. Meaning of Lexatumumab. Synonyms of Lexatumumab

Here you will find one or more explanations in English for the word Lexatumumab. Also in the bottom left of the page several parts of wikipedia pages related to the word Lexatumumab and, of course, Lexatumumab synonyms and on the right images related to the word Lexatumumab.

Definition of Lexatumumab

No result for Lexatumumab. Showing similar results...

Meaning of Lexatumumab from wikipedia

- Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2), intended for the treatment...
- Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab Mapatumumab Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab...
- levotofisopam (USAN) levoxadrol (INN) levoxyl levulan lexacalcitol (INN) lexapro lexatumumab (INN) lexgenleucel-T (USAN) lexipafant (INN) lexithromycin (INN) lexiva...
- necrosis factor related activation protein (TRAP) inflammatory diseases Lexatumumab mab human TRAIL-R2 cancer Libivirumab mab human hepatitis B surface antigen...
- Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab Mapatumumab Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab...
- Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab Mapatumumab Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab...
- Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab Mapatumumab Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab...
- therapeutics. This deal generated belimumab, raxiba****ab, mapatumumab and lexatumumab. In April 2012, the first three of these products formed part of the...
- Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab Mapatumumab Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab...
- Conatumumab Dacetuzumab Denosumab Drozitumab Enavatuzumab Iratumumab Lexatumumab Lucatumumab Mapatumumab Oxelumab Ruplizumab Tabalumab Tavolixizumab Teneliximab...